Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). Co. designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. Co. offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. We show 11 historical shares outstanding datapoints in our LFCR shares outstanding history coverage, used to compute LFCR market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing LFCR market cap history over the course of time is important for investors
interested in comparing LFCR's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of LFCR versus a peer is one thing; comparing
LFCR market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like LFCR can fluctuate over the course of history.
With this page we aim to empower investors researching LFCR by allowing them to research the LFCR market cap history. |
Free LFCR Email Alerts:
Video: The Importance of Market Cap
